Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bayer Schering Pharma AG, Germany is starting Phase III with an innovative patch for female contraception that combines low dosed ethinylestradiol and gestodene. Approximately 3300 women will be enrolled into two global studies to evaluate the contraceptive reliability of the patch starting in May 2009. It is planned to submit the new patch for registration worldwide. First filing is expected in 2012.

Today in Dosing...keeping you current

Abbott Seeks FDA Approval of New Dosage Strengths of SIMCOR
Abbott, 12/11/09

Voriconazole Pharmacokinetics and Pharmacodynamics in Children
Clinical Infectious Diseases, 12/11/09

Congenital abnormalities in children of 43 pregnant women who attempted suicide with large doses of nitrazepam
Pharmacoepidemiology and Drug Safety, 12/09/09

Today in Other Drugs...keeping you current

New central targets for the treatment of obesity
British Journal of Clinical Pharmacology, 12/11/09

Metformin increases plasma ghrelin in Type 2 diabetes
British Journal of Clinical Pharmacology, 12/11/09

Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation
Core Evidence, 12/11/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address